AGP Executive Report
Last update: 2 hours agoEarlier Cancer Detection: More than 20,000 patients at 200 GP surgeries in England will be offered blood tests screening for signs of 13 cancers, in an £8.5m trial assessing whether the tests can help GPs identify who needs urgent investigation. Children’s A&E: The NHS plans to roll out a new early-warning system to help staff spot seriously ill children faster, following the death of two-year-old Finlay after hours in an A&E corridor. Forever Chemicals: UKHSA is testing blood and urine samples to establish how much PFAS people in England are exposed to; initial findings are expected in 2027. Child Health: New figures show 11% of children in England are obese by their first year of primary school, with deprivation linked to widening gaps. NHS Treatment: The health service has delivered one million more scans, while a breast cancer drug that can extend life is now available on the NHS. Inhaler Innovation: Scottish medtech firm 1nhaler has raised £2.2m to develop a cardboard salbutamol inhaler, with a small clinical trial planned ahead of a targeted 2027 regulatory filing.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
